다우존스 지수

실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

등록

IRWD Ironwood Pharmaceuticals Inc

3.69

0.00 (0.00%)

시간외 단일가

최종 업데이트: 18:00:00

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Shares sold to cover taxes from the vesting of stock awards granted by the Issuer.

Date of Notice

05/17/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Michael Shetzline

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Ironwood Pharmaceuticals (NASDAQ:IRWD)
과거 데이터 주식 차트
부터 11월(11) 2024 으로 12월(12) 2024

Ironwood Pharmaceuticals 차트를 더 보려면 여기를 클릭.

Ironwood Pharmaceuticals (NASDAQ:IRWD)
과거 데이터 주식 차트
부터 12월(12) 2023 으로 12월(12) 2024

Ironwood Pharmaceuticals 차트를 더 보려면 여기를 클릭.

Ironwood Pharmaceuticals Inc News

Form 8-K - Current report
0년 6월 12일, 2024 (7 일 전) • Edgar (US Regulatory)

Ironwood Pharmaceuticals to Participate in the Piper Sandler 36th Annual Healthcare Conference
0년 27월 11일, 2024 (2 주 전) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
0년 21월 11일, 2024 (3 주 전) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
0년 21월 11일, 2024 (3 주 전) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
0년 16월 11일, 2024 (4 주 전) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
0년 16월 11일, 2024 (4 주 전) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
0년 15월 11일, 2024 (4 주 전) • Edgar (US Regulatory)

Ironwood Pharmaceuticals to Participate in the Jefferies London Healthcare Conference
0년 14월 11일, 2024 (4 주 전) • Business Wire

Form 8-K - Current report
0년 13월 11일, 2024 (4 주 전) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
0년 8월 11일, 2024 (1 월 전) • Edgar (US Regulatory)

Form 8-K - Current report
0년 7월 11일, 2024 (1 월 전) • Edgar (US Regulatory)

Ironwood Pharmaceuticals Reports Third Quarter 2024 Results
0년 7월 11일, 2024 (1 월 전) • Business Wire

More Ironwood Pharmaceuticals Inc News Articles

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관